The Medicinal Cannabis (R)evolution

REFERENCES

Abuhasira, R. Schleider, L.B.L. Mechoulam, R. and Novack, V. 2018. Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly. European Journal of Internal Medicine , 49: 44-50. Alleyne, M.T.S.C. Bouhga-Hagbe, M.J. Dowling, M.T. Kovtun, D. Myrvoda, M.A. Okwuokei, M.J.C. and Turunen, M.J. 2017. Loss of Correspondent Banking Relationships in the Caribbean: Trends, Impact, and Policy Options . International Monetary Fund. Antigua Observer 2018. Another Step Towards Legalising Marijuana. Available at https://antiguaobserver.com/another-step-towards-legalising-marijuana-for-medicine-and- religion/ Belackova, V. Ritter, A. Shanahan, M. Chalmers, J. Hughes, C. Barratt, M. and Lancaster, K. 2015. Medicinal cannabis in Australia–Framing the regulatory options . Sydney: Drug Policy Modelling Program.

Bewley-Taylor, D. Jelsma, M. Rolles, S. and Walsh, J. 2016. Cannabis regulation and the UN drug treaties: Strategies for reform .

Boehnke, K.F. Litinas, E. and Clauw, D.J. 2016. Medical cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain. The Journal of Pain 17(6): 739-744. CARICOM 2018, Report of the CARICOM Regional Commission on Marijuana 2018: Waiting to Exhale – Safeguarding our Future through Responsible Socio-Legal Policy on Marijuana . Caribbean Community Secretariat, Georgetown.

Carpentier, C. (ed.) 2012. Cannabis production and markets in Europe . Publications Office of the European Union.

v